These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 19580781

  • 1. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
    Kumar S, Sarkar A, Sundar D.
    Biochem Biophys Res Commun; 2009 Sep 18; 387(2):305-9. PubMed ID: 19580781
    [Abstract] [Full Text] [Related]

  • 2. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM.
    Exp Neurol; 2004 Jun 18; 187(2):279-88. PubMed ID: 15144854
    [Abstract] [Full Text] [Related]

  • 3. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C, Chang JY.
    Biochemistry; 2007 Jan 16; 46(2):602-9. PubMed ID: 17209570
    [Abstract] [Full Text] [Related]

  • 4. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E, Fantini J, Chahinian H, Maresca M, Taïeb N, Yahi N.
    J Mol Biol; 2010 Mar 19; 397(1):202-18. PubMed ID: 20114052
    [Abstract] [Full Text] [Related]

  • 5. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease.
    Bharathi, Rao KS.
    Biochem Biophys Res Commun; 2007 Jul 20; 359(1):115-20. PubMed ID: 17531952
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE.
    J Mol Biol; 2002 Jan 25; 315(4):799-807. PubMed ID: 11812148
    [Abstract] [Full Text] [Related]

  • 8. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K, Ikeda T, Takasaki J, Yamada M.
    Neurobiol Dis; 2011 Sep 25; 43(3):715-24. PubMed ID: 21684335
    [Abstract] [Full Text] [Related]

  • 9. Binding of Cu(II) to human alpha-synucleins: comparison of wild type and the point mutations associated with the familial Parkinson's disease.
    Hong L, Simon JD.
    J Phys Chem B; 2009 Jul 16; 113(28):9551-61. PubMed ID: 19548659
    [Abstract] [Full Text] [Related]

  • 10. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H, Celej MS, Becker S, Riedel D, Pelah A, Kumar A, Jovin TM, Baldus M.
    J Mol Biol; 2008 Jul 11; 380(3):444-50. PubMed ID: 18539297
    [Abstract] [Full Text] [Related]

  • 11. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
    Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, Crowther RA, Goedert M.
    FEBS Lett; 2004 Oct 22; 576(3):363-8. PubMed ID: 15498564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA.
    Neurobiol Dis; 2005 Apr 22; 18(3):492-8. PubMed ID: 15755676
    [Abstract] [Full Text] [Related]

  • 15. Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers.
    Brucale M, Sandal M, Di Maio S, Rampioni A, Tessari I, Tosatto L, Bisaglia M, Bubacco L, Samorì B.
    Chembiochem; 2009 Jan 05; 10(1):176-83. PubMed ID: 19067456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C, Lee SJ.
    J Neurochem; 2008 Oct 05; 107(2):303-16. PubMed ID: 18691382
    [Abstract] [Full Text] [Related]

  • 18. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
    Celej MS, Caarls W, Demchenko AP, Jovin TM.
    Biochemistry; 2009 Aug 11; 48(31):7465-72. PubMed ID: 19586054
    [Abstract] [Full Text] [Related]

  • 19. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ, Choi MY, Im H.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):165-9. PubMed ID: 19501571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.